Pfizer acquires 40% stake in Brazilian generics firm Teuto
This article was originally published in Scrip
Executive Summary
Pfizer says it is aiming to boost its presence in Brazil by acquiring a 40% stake in the local generics firm Teuto, in a deal worth an initial $240 million. Through the agreement, the two companies will develop and commercialise generic medicines, said Pfizer.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.